Amyloid burden assessed by three amyloid PET tracers in the elenbecestat MissionAD Phase 3 program: Neuroimaging / evaluating treatments
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI